First Header Logo Second Header Logo

Search Results (548)

MatchTypeWhy
Leveraging Digital Health Technologies and Outpatient Sampling in Clinical Drug Development: A Phase I Exploratory Study.Academic Article Why?
Model Informed Drug Development: Novel Oncology Agents are Lost in Translation.Academic Article Why?
Improved methodology for identifying the teratogenic potential in early drug development of hERG channel blocking drugs.Academic Article Why?
Report of the Assay Guidance Workshop on 3-Dimensional Tissue Models for Antiviral Drug Development.Academic Article Why?
3D optical/CT as a preclinical companion imaging platform for glioblastoma drug development.Academic Article Why?
Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy.Academic Article Why?
Optimal Dosing for Targeted Therapies in Oncology: Drug Development Cases Leading by Example.Academic Article Why?
Editorial: Preclinical Animal Models and Measures of Pain: Improving Predictive Validity for Analgesic Drug Development.Academic Article Why?
Lung-On-A-Chip Technologies for Disease Modeling and Drug Development.Academic Article Why?
Spinal cord injury pharmacotherapy: Current research & development and competitive commercial landscape as of 2015.Academic Article Why?
Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA-AA Research Framework.Academic Article Why?
Multiscale Modeling in the Clinic: Drug Design and Development.Academic Article Why?
Applications of Bioengineered 3D Tissue and Tumor Organoids in Drug Development and Precision Medicine: Current and Future.Academic Article Why?
Best practices for detection, assessment and management of suspected immune-mediated liver injury caused by immune checkpoint inhibitors during drug development.Academic Article Why?
McNutt, PatrickPerson Why?
Per Page    Page  of 37last Nextnext
Prev
Search Criteria
  • Drug
  • development
Filter by Type
_
Click "Why?" to see why an item matched the search.